Mandos LLC
USPTO PatentsView assignee record - 20 granted patents across 2 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Mandos ranks #14,761 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 2 technology areas.
- #14,761
- of 49,997 US assignees by volume
- Top 17%
- by Innovation Score (48.5/100)
- 21.6
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R14761 · US Corporation #14,761 · 20 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH
- GRANTS-SMALL 20 grants
- MID-PACK #14,761/49,997
- PHOTO-FINISH M2 Distribution
- CPC-NARROW A61P · 2 areas
- INNOV-PAR 48.5/100
- CLAIMS-DENSE 21.6 claims/avg
- TYPE-USCORP US Corporation
- SPAN-YRS 2022–2025 · 4y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: M2 Distribution Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Mandos’s 48.5 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Mandos
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Mandos · this assignee
Mandos · this assignee
48 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Mandos's Innovation Score is 48.5/100 (top 17% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Mandos?
Each dot is one of Mandos’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Mandos’s own 21.6 claims/patent is ABOVE the 16.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Mandos's grants concentrate
Mandos LLC is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2023 (8 grants) versus a trough of 3 in 2024. By volume, Mandos sits between M.M.A. Design, LLC and Medicell Technologies, LLC.
Mandos's three-year grant acceleration
Mandos LLC shows 17 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Mandos's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- M M A Design
M.M.A. Design, LLC
20 patents
- M2 Distribution
M2 Distribution Ltd.
20 patents
- M3 Health INDÚStr…
M3 Health INDÚSTRIA E COMÉRCIO DE Produtos MÉDICOS, ODONTOLÓGICOS E Correlatos S.A.
20 patents
- Macquarie Univers…
Macquarie University
20 patents
- Marel Townsend Fu…
Marel Townsend Further Processing B.V.
20 patents
- Maven Optronics
Maven Optronics Co., Ltd.
20 patents
- Meco
Meco SA
20 patents
- Medicell
Medicell Technologies, LLC
20 patents
- Mandos ◀
Mandos LLC
20 patents
What this shows Mandos holds 20 patents at rank #14,756, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Mandos
By rank, the assignees closest to #14,756 in granted patent volume.
- M.M.A. Design, LLC #14,752 · 20 patents
- M2 Distribution Ltd. #14,753 · 20 patents
- M3 Health INDÚSTRIA E COMÉRCIO DE Produtos MÉDICOS, ODONTOLÓGICOS E Correlatos S.A. #14,754 · 20 patents
- Macquarie University #14,755 · 20 patents
- Marel Townsend Further Processing B.V. #14,757 · 20 patents
- Maven Optronics Co., Ltd. #14,758 · 20 patents
- Meco SA #14,759 · 20 patents
- Medicell Technologies, LLC #14,760 · 20 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Mandos's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Mandos's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
48 Top 17% higher than 83% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2022 | 6 | 30.0% |
| 2023 | 8 | 40.0% |
| 2024 | 3 | 15.0% |
| 2025partial year | 3 | 15.0% |
Which technologies does Mandos LLC patent most?
Top 2 of 2 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Mandos LLC's patent record in context - here's where to go next.
- Mandos LLC's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #14,761 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Mandos LLC against M.M.A. Design, LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 48.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.